This partnership marks a transformative shift in healthcare from reactive diagnosis to proactive, AI-driven prediction. With arrhythmias often going undetected until severe outcomes occur, early identification in populations with chronic conditions like diabetes and COPD can reduce hospitalizations, lower costs, and improve quality of life. The collaboration aligns with the healthcare industry’s growing emphasis on value-based care, making this innovation pivotal for scalable, efficient patient management.